A tripeptide that carries a metal
GHK is the sequence glycyl-L-histidyl-L-lysine, found naturally in human plasma. On its own it is a small, unremarkable tripeptide. What makes it a research subject is its high affinity for copper(II) ions: the histidine imidazole and the peptide backbone coordinate Cu²⁺ tightly, forming the GHK-Cu complex. The copper-bound form is what appears throughout the literature, and treating GHK and GHK-Cu as interchangeable is a common error — the complex is the studied entity.
Copper-ion delivery as a mechanism
Much of the attributed activity is understood as copper delivery. Copper is an essential cofactor for enzymes involved in connective-tissue chemistry — lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase, an antioxidant enzyme, among them. Free copper ions are reactive and tightly regulated in biology; a peptide that binds and shuttles copper in a controlled form is a plausible way to make the ion available where it can be used. In research models, this framing explains why the complex behaves differently than either component alone.
Broad transcriptomic modulation
The more striking research finding is scale. Transcriptomic studies report changes across thousands of genes in the presence of GHK-Cu, with a substantial subset relating to extracellular-matrix (ECM) remodeling and collagen synthesis. This breadth is why GHK-Cu is classified as a genomic research compound rather than a single-target ligand: the observed profile is a shift in expression patterns, not a discrete receptor interaction.
That breadth is also the mechanistic caveat. A signature spanning thousands of genes describes what changes, not what causes the change. The upstream trigger — how much is copper availability, how much is the peptide itself — remains an open question in the literature.
ECM remodeling and fibroblast models
The most common experimental context is the dermal fibroblast — the cell responsible for producing collagen and maintaining the extracellular matrix. Studies in fibroblast and skin-model systems examine ECM component synthesis, remodeling signaling, and antioxidant-related responses. These are cell-culture and model systems; results describe behavior in those systems only.
What the mechanism does not establish
Copper coordination chemistry is well characterized, and expression-profiling data is real data — but neither establishes an outcome in any living human or animal context. Broad transcriptomic activity in particular is easy to over-read. GHK-Cu is not approved for human or veterinary use, and no dosing, cosmetic, or therapeutic guidance exists or is provided here.
Reference data
| Compound | GHK-Cu · Copper tripeptide-1 |
| Molecular weight | 404.92 g/mol |
| Sequence / form | Gly-His-Lys (copper-bound) |
| Research class | Genomic |
| Verification | Independent five-point panel (MZ Biolabs, Arizona) — lot-specific COA |
Where it appears in research
- Extracellular-matrix and collagen-synthesis studies
- Transcriptomic / gene-expression profiling
- Dermal fibroblast and skin-model research
- Copper-homeostasis and antioxidant assays
Ethos Bio supplies GHK-Cu strictly as a research reagent. Every lot is independently verified by MZ Biolabs, a third-party analytical laboratory in Arizona, on a five-point panel — RP-HPLC purity, HPLC-MS identity, endotoxin (LAL), heavy metals, and sterility — with a lot-specific Certificate of Analysis shipped alongside the vial.
GHK-Cu reference materials
Read the full monograph for sequence, specifications, and research context, or review the lot-specific certificate of analysis.
Frequently asked questions
What is the mechanism of action of GHK-Cu?
In research models GHK-Cu acts largely through copper(II) delivery and broad modulation of gene expression. Transcriptomic studies report changes across thousands of genes, many related to extracellular-matrix remodeling and collagen synthesis. Findings are limited to cell-culture and model systems.
Why is GHK bound to copper?
The GHK tripeptide has high affinity for copper(II) ions, and the copper complex is the form studied in the research literature. Copper is a cofactor for enzymes involved in collagen cross-linking and antioxidant activity, which is central to how the complex’s activity is interpreted.
Is GHK-Cu a single-target compound?
No. Its research profile is characterized by broad transcriptomic changes rather than a discrete receptor interaction, which is why it is classified as a genomic research compound. The upstream driver of those changes remains an open research question.
Is GHK-Cu approved for human use?
No. GHK-Cu is sold strictly for laboratory research use only. It is not a drug, supplement, or cosmetic product and is not approved for human or veterinary use or consumption.